High level protein expression in mammalian cells using a safe viral vector: Modified vaccinia virus Ankara

Protein Expression and Purification

Volumn 56, Issue 2, 2007, Pages 269-278

  Hebben, Matthias ^a   Brants, Jan ^a   Birck, Catherine ^a   Samama, Jean Pierre ^a   Wasylyk, Bohdan ^a   Spehner, Danièle ^a   Pradeau, Karine ^a   Domi, Arban ^b   Moss, Bernard ^b   Schultz, Patrick ^a   Drillien, Robert ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Bacteriophage T7; Modified vaccinia virus Ankara (MVA); Protein expression; Tubulin tyrosine ligase; Vaccinia virus

Indexed keywords

LIGASE; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; HAMSTER; HUMAN; KINETICS; METABOLISM; REPORTER GENE; VACCINIA VIRUS;

ANIMALS; CELLS, CULTURED; CRICETINAE; GENE EXPRESSION REGULATION, VIRAL; GENES, REPORTER; GENETIC VECTORS; HUMANS; KINETICS; LIGASES; RECOMBINANT PROTEINS; VACCINIA VIRUS;

ENCEPHALOMYOCARDITIS VIRUS; ESCHERICHIA COLI; MAMMALIA; VACCINIA VIRUS; VACCINIA VIRUS ANKARA;

EID: 35549000565     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2007.08.003     Document Type: Article

References (31)

1. Mackett M., Smith G.L., and Moss B. Vaccinia virus: a selectable eukaryotic cloning and expression vector. Proc. Natl. Acad. Sci. USA 79 (1982) 7415-7419
2. Panicali D., and Paoletti E. Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus. Proc. Natl. Acad. Sci. USA 79 (1982) 4927-4931
3. Carroll M.W., and Moss B. Poxviruses as expression vectors. Curr. Opin. Biotechnol. 8 (1997) 573-577
4. Smith G.L., and Moss B. Infectious poxvirus vectors have capacity for at least 25 000 base pairs of foreign DNA. Gene 25 (1983) 21-28
5. Fuerst T.R., Earl P.L., and Moss B. Use of a hybrid vaccinia virus-T7 RNA polymerase system for expression of target genes. Mol. Cell. Biol. 7 (1987) 2538-2544
6. Mohamed M.R., and Niles E.G. Transient and inducible expression of vaccinia/T7 recombinant viruses. Methods Mol. Biol. 269 (2004) 41-50
7. Alexander W.A., Moss B., and Fuerst T.R. Regulated expression of foreign genes in vaccinia virus under the control of bacteriophage T7 RNA polymerase and the Escherichia coli lac repressor. J. Virol. 66 (1992) 2934-2942
8. Ward G.A., Stover C.K., Moss B., and Fuerst T.R. Stringent chemical and thermal regulation of recombinant gene expression by vaccinia virus vectors in mammalian cells. Proc. Natl. Acad. Sci. USA 92 (1995) 6773-6777
9. Elroy-Stein O., Fuerst T.R., and Moss B. Cap-independent translation of mRNA conferred by encephalomyocarditis virus 5′ sequence improves the performance of the vaccinia virus/bacteriophage T7 hybrid expression system. Proc. Natl. Acad. Sci. USA 86 (1989) 6126-6130
10. Vennema H., Rijnbrand R., Heijnen L., Horzinek M.C., and Spaan W.J. Enhancement of the vaccinia virus/phage T7 RNA polymerase expression system using encephalomyocarditis virus 5'-untranslated region sequences. Gene 108 (1991) 201-209
11. Mayr A. TC marker of the attenuated vaccinia vaccide strain "MVA" in human cell cultures and protective immunization against orthopox diseases in animals. Zentralbl. Veterinarmed. B 23 (1976) 417-430
12. Meyer H., Sutter G., and Mayr A. Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence. J. Gen. Virol. 72 Pt 5 (1991) 1031-1038
13. Stittelaar K.J., Kuiken T., de Swart R.L., van Amerongen G., Vos H.W., Niesters H.G., van Schalkwijk P., van der Kwast T., Wyatt L.S., Moss B., and Osterhaus A.D. Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques. Vaccine 19 (2001) 3700-3709
14. Mayr A., Stickl H., Muller H.K., Danner K., and Singer H. The smallpox vaccination strain MVA: marker, genetic structure, experience gained with the parenteral vaccination and behavior in organisms with a debilitated defence mechanism (author's transl). Zentralbl. Bakteriol. [B] 167 (1978) 375-390
15. Wyatt L.S., Moss B., and Rozenblatt S. Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells. Virology 210 (1995) 202-205
16. Sutter G., Ohlmann M., and Erfle V. Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase. FEBS Lett. 371 (1995) 9-12
17. Spehner D., Drillien R., Proamer F., Houssais-Pecheur C., Zanta M.A., Geist M., Dott K., and Balloul J.M. Enveloped virus is the major virus form produced during productive infection with the modified vaccinia virus Ankara strain. Virology 273 (2000) 9-15
18. Howley P.M., Spehner D., and Drillien R. A vaccinia virus transfer vector using a GUS reporter gene inserted into the I4L locus. Gene 172 (1996) 233-237
19. Davison A.J., and Moss B. Structure of vaccinia virus early promoters. J. Mol. Biol. 210 (1989) 749-769
20. Lorenzo M.M., and Blasco R. PCR-based method for the introduction of mutations in genes cloned and expressed in vaccinia virus. Biotechniques 24 (1998) 308-313
21. Falkner F.G., and Moss B. Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors. J. Virol. 62 (1988) 1849-1854
22. Chakrabarti S., Brechling K., and Moss B. Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques. Mol. Cell. Biol. 5 (1985) 3403-3409
23. Panicali D., Grzelecki A., and Huang C. Vaccinia virus vectors utilizing the beta-galactosidase assay for rapid selection of recombinant viruses and measurement of gene expression. Gene 47 (1986) 193-199
24. Roederer M., Staal F.J., Raju P.A., Ela S.W., Herzenberg L.A., and Herzenberg L.A. Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-l-cysteine. Proc. Natl. Acad. Sci. USA 87 (1990) 4884-4888
25. Maniatis T., Fritsch E., and Sambrook J. Molecular Cloning: "A Laboratory Manual" (1989), Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
26. Antoine G., Scheiflinger F., Dorner F., and Falkner F.G. The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses. Virology 244 (1998) 365-396
27. Ersfeld K., Wehland J., Plessmann U., Dodemont H., Gerke V., and Weber K. Characterization of the tubulin-tyrosine ligase. J. Cell. Biol. 120 (1993) 725-732
28. Mialhe A., Lafanechere L., Treilleux I., Peloux N., Dumontet C., Bremond A., Panh M.H., Payan R., Wehland J., Margolis R.L., and Job D. Tubulin detyrosination is a frequent occurrence in breast cancers of poor prognosis. Cancer Res. 61 (2001) 5024-5027
29. Bleckwenn N.A., Bentley W.E., and Shiloach J. Exploring vaccinia virus as a tool for large-scale recombinant protein expression. Biotechnol. Prog. 19 (2003) 130-136
30. Sanger C., Muhlberger E., Klenk H.D., and Becker S. Adverse effects of MVA-T7 on the transport of Marburg virus glycoprotein. J. Virol. Methods 91 (2001) 29-35
31. Sutter G., and Moss B. Nonreplicating vaccinia vector efficiently expresses recombinant genes. Proc. Natl. Acad. Sci. USA 89 (1992) 10847-10851